Shilin Huang - Search Results

Year	Number of Results
2003	2
2004	1
2005	2
2007	1
2008	6
2009	2
2010	1
2013	1
2014	1
2015	1
2016	5
2017	2
2018	2
2019	2
2020	2
2021	3
2022	3
2023	7
2024	5

1

Chen L, Huang S, Ras RHA, Tian X. Chen L, et al. Among authors: huang s. Nat Rev Chem. 2023 Feb;7(2):123-137. doi: 10.1038/s41570-022-00455-w. Epub 2023 Jan 9. Nat Rev Chem. 2023. PMID: 37117914 Review.

2

Progress of research on molecular targeted therapies for colorectal cancer.

Huang S, Ye J, Gao X, Huang X, Huang J, Lu L, Lu C, Li Y, Luo M, Xie M, Lin Y, Liang R. Huang S, et al. Front Pharmacol. 2023 Aug 8;14:1160949. doi: 10.3389/fphar.2023.1160949. eCollection 2023. Front Pharmacol. 2023. PMID: 37614311 Free PMC article. Review.

3

The mechanisms and functions of TGF-β1 in tendon healing.

Li H, Luo S, Wang H, Chen Y, Ding M, Lu J, Jiang L, Lyu K, Huang S, Shi H, Chen H, Li S. Li H, et al. Among authors: huang s. Injury. 2023 Nov;54(11):111052. doi: 10.1016/j.injury.2023.111052. Epub 2023 Sep 15. Injury. 2023. PMID: 37738787 Review.

4

Publisher Correction: Omniphobic liquid-like surfaces.

Chen L, Huang S, Ras RHA, Tian X. Chen L, et al. Among authors: huang s. Nat Rev Chem. 2023 Nov;7(11):813. doi: 10.1038/s41570-023-00549-z. Nat Rev Chem. 2023. PMID: 37783823 No abstract available.

5

Research progress of the netrins and their receptors in cancer.

Gao X, Ye J, Huang X, Huang S, Luo W, Zeng D, Li S, Tang M, Mai R, Li Y, Lin Y, Liang R. Gao X, et al. Among authors: huang s. J Cell Mol Med. 2024 Apr;28(8):e18241. doi: 10.1111/jcmm.18241. J Cell Mol Med. 2024. PMID: 38546656 Free PMC article. Review.

6

RBM38 Reverses Sorafenib Resistance in Hepatocellular Carcinoma Cells by Combining and Promoting lncRNA-GAS5.

Gao X, Lu C, Liu Z, Lin Y, Huang J, Lu L, Li S, Huang X, Tang M, Huang S, He Z, She X, Liang R, Ye J. Gao X, et al. Among authors: huang s. Cancers (Basel). 2023 May 24;15(11):2897. doi: 10.3390/cancers15112897. Cancers (Basel). 2023. PMID: 37296859 Free PMC article.

7

Whether and When Superhydrophobic/Superoleophobic Surfaces Are Fingerprint Repellent.

Wu C, Fan Y, Wang H, Li J, Chen Y, Wang Y, Liu L, Zhou L, Huang S, Tian X. Wu C, et al. Among authors: huang s. Research (Wash D C). 2022 Sep 23;2022:9850316. doi: 10.34133/2022/9850316. eCollection 2022. Research (Wash D C). 2022. PMID: 36258844 Free PMC article.

8

Integrative single-cell transcriptomic analyses reveal the cellular ontological and functional heterogeneities of primary and metastatic liver tumors.

Gui M, Huang S, Li S, Chen Y, Cheng F, Liu Y, Wang JA, Wang Y, Guo R, Lu Y, Cao P, Zhou G. Gui M, et al. Among authors: huang s. J Transl Med. 2024 Feb 27;22(1):206. doi: 10.1186/s12967-024-04947-9. J Transl Med. 2024. PMID: 38414027 Free PMC article.

9

Prognosis-Related Molecular Subtypes and Immune Features Associated with Hepatocellular Carcinoma.

Ye J, Lin Y, Gao X, Lu L, Huang X, Huang S, Bai T, Wu G, Luo X, Li Y, Liang R. Ye J, et al. Among authors: huang s. Cancers (Basel). 2022 Nov 21;14(22):5721. doi: 10.3390/cancers14225721. Cancers (Basel). 2022. PMID: 36428813 Free PMC article.

10

A Case of Curative Treatment with Apatinib and Camrelizumab Following Liver Resection for Advanced Hepatocellular Carcinoma.

Huang J, Liang R, Lu C, Lu L, Li S, Tang M, Huang X, Huang S, Mai R, Gao X, Li S, Zeng C, Lin Y, Ye J. Huang J, et al. Among authors: huang s. Int J Mol Sci. 2023 Aug 30;24(17):13486. doi: 10.3390/ijms241713486. Int J Mol Sci. 2023. PMID: 37686291 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

47 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year